Filter
1427
Text search:
drug
approval
Featured
Recommendations
95
New Publications
409
Language
Document type
No document type
838
Studies & Reports
258
Guidelines
180
Manuals
61
Strategic & Response Plan
40
Fact sheets
26
Training Material
15
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
India
93
Global
47
Uganda
43
Kenya
42
Nigeria
37
South Africa
36
Malawi
34
Ethiopia
31
Nepal
28
Western and Central Europe
28
Myanmar / Burma
26
Tanzania
25
Sierra Leone
24
Liberia
23
Ghana
22
Zambia
22
Ukraine
22
Bangladesh
21
Rwanda
20
Namibia
19
Latin America and the Carribbean
18
Lesotho
16
Zimbabwe
14
Africa
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
9
Burkina Faso
8
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Thailand
6
Pakistan
5
Syria
5
China
5
Mozambique
5
Benin
5
Tajikistan
5
Russia
5
USA
4
Cameroon
4
South Sudan
4
Indonesia
4
Peru
4
East and Southern Africa
4
Albania
4
Germany
3
Eswatini/ Swaziland
3
West and Central Africa
3
Venezuela
3
Georgia
3
Vietnam
3
Somalia
2
Central African Republic
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Guinea
1
Iraq
1
Afghanistan
1
Lebanon
1
Sudan
1
Argentina
1
Brazil
1
Colombia
1
Libya
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
629
Clinical Guidelines
118
Public Health
41
Key Resources
38
Women & Child Health
35
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
176
TB
134
AMR
102
Mental Health
72
COVID-19
72
Pharmacy
64
NTDs
54
Ebola & Marburg
25
NCDs
24
Rapid Response
22
Caregiver
21
Health Financing Toolbox
17
Planetary Health
16
Malaria
15
Global Health Education
12
Conflict
11
Refugee
11
2.0 Rapid Response
10
Disability
9
Zika
7
Polio
5
Natural Hazards
4
Specific Hazards
4
Cholera
1
Social Ethics
1
Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex
...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin
...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and
...
International Journal of Advances in Medicine. Vol. 7 No. 7 (2020): July 2020 . This study explores the clinical characteristics and outcomes of patients with concurrent malaria and HIV infection, a combination that is relatively understudied in India.
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl
...
AIDS 2024, 38:1579–1588. Treatment interruptions are a barrier to successful antiretroviral therapy (ART). 'Fresh start messages', which leverage significant days on the calendar (e.g., new year, public holiday) in order to prompt action, have the potential to encourage people with HIV (PWH) to re
...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Toolkit
HIV Treatment and Care
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon
...
Globally, the cancer burden is rising, exerting significant strain on
populations and health systems at all levels of income. There are
concerted efforts towards enhancing access to comprehensive
cancer prevention and control initiatives.